CA
AMGN icon

Crumly & Associates’s Amgen AMGN Stock Holding History

Crumly & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Sell
1,128
-805
-42% -$276K 0.08% 137
2026
Q1 		$680K Buy
1,933
+104
+6% +$37.1K 0.14% 94
2025
Q4 		$599K Buy
1,829
+427
+30% +$135K 0.13% 96
2025
Q3 		$396K Buy
1,402
+256
+22% +$74.2K 0.09% 134
2025
Q2 		$320K Buy
1,146
+36
+3% +$10.2K 0.08% 126
2025
Q1 		$346K Buy
1,110
+100
+10% +$29.5K 0.1% 118
2024
Q4 		$263K Buy
1,010
+40
+4% +$11.9K 0.07% 128
2024
Q3 		$313K Buy
970
+98
+11% +$32.1K 0.09% 119
2024
Q2 		$272K Buy
+872
New +$256K 0.08% 125

Other funds holding AMGN

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Crumly & Associates's AMGN Position: Q2 2026 in Review

Crumly & Associates reduced its Amgen (AMGN) stake by 42% in Q2 2026, selling an estimated $276K and leaving 1,128 shares worth $408K. The position accounts for 0.08% of the portfolio, ranked #137.

Crumly & Associates first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $680K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Crumly & Associates held 1,128 shares of Amgen worth $408K as of Q2 2026.
  • Crumly & Associates sold 805 Amgen shares in Q2 2026, an estimated $276K.
  • Amgen made up 0.08% of Crumly & Associates's portfolio in Q2 2026, its #137 holding.
  • Crumly & Associates first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • Crumly & Associates's Amgen position peaked at $680K in Q1 2026.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.